Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS)
CNY 12.03
(0.17%)
CNY 12.03
(0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.74 Billion | 2.85 Billion | 1.67 Billion | 1.56 Billion | 1.27 Billion | 1.66 Billion |
| Net Income | 691.88 Million | 867.48 Million | 821.14 Million | 900.04 Million | 928.46 Million | 1.06 Billion |
| Depreciation & Amortization | 825.24 Million | 842.48 Million | 820.26 Million | 726.41 Million | 722.4 Million | 731.76 Million |
| Deferred income taxes | -11.44 Million | -56.98 Million | -27.54 Million | 5.98 Million | 69.69 Million | -51.48 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -183.92 Million | 1 Billion | -309.4 Million | -301.95 Million | -672.14 Million | -15.68 Million |
| Other non-cash items | 2.25 Billion | 144.66 Million | 347.65 Million | 235.67 Million | 291.41 Million | -116.92 Million |
| Investing Cash Flow | -1.38 Billion | -302.43 Million | -508.27 Million | -557.09 Million | -333.28 Million | 51.19 Million |
| Investments in PPE | -357.19 Million | -307.44 Million | -521.44 Million | -377.97 Million | -403.82 Million | -399.4 Million |
| Acquisitions | 10.95 Million | 5 Million | 3.72 Million | 26.02 Million | 2.03 Million | 2.25 Million |
| Investment purchases | 1.00 | - | -3.72 Million | -210 Million | -2.03 Million | -12 Million |
| Sales/Maturities of investments | 2 Million | - | 9.44 Million | 4.75 Million | 23.52 Million | 442.64 Million |
| Other Investing Activities | -1.04 Billion | 0.98 | 3.72 Million | 106.01 Thousand | 47.02 Million | 17.7 Million |
| Financing Cash Flow | -1.09 Billion | -435.31 Million | -662.4 Million | -1.96 Billion | -140.86 Million | -652.6 Million |
| Debt repayment | -707.8 Million | -3.18 Billion | -3.34 Billion | -3.6 Billion | -3.4 Billion | -2.39 Billion |
| Dividends payments | -134.11 Million | -102.69 Million | -102.69 Million | -102.69 Million | -105.62 Million | -456.88 Million |
| Common Stock Repurchased | - | -1.18 Billion | - | - | - | - |
| Common Stock Issuance | - | 1.18 Billion | - | - | - | - |
| Other Financing Activities | -251.47 Million | 2.93 Billion | 2.89 Billion | 1.85 Billion | 3.58 Billion | 2.19 Billion |
| Accounts receivables | 485.42 Million | 463.12 Million | -921.35 Million | -993.23 Million | -376.87 Million | 237.9 Million |
| Accounts payables | -832.61 Million | -30.38 Million | 444.17 Million | 1.65 Billion | -334.21 Million | 180.94 Million |
| Inventory | 163.26 Million | 625.23 Million | 195.3 Million | -966.63 Million | -30.75 Million | -396.59 Million |
| Other working capital | 2.00 | -56.98 Million | -27.54 Million | 5.98 Million | 69.69 Million | 380.91 Million |
| Cash at beginning of period | 6.14 Billion | 3.62 Billion | 3.15 Billion | 4.16 Billion | 3.35 Billion | 2.28 Billion |
| Cash at end of period | 5.22 Billion | 5.83 Billion | 3.62 Billion | 3.15 Billion | 4.16 Billion | 3.35 Billion |
| Capital Expenditure | -357.19 Million | -307.44 Million | -521.44 Million | -377.97 Million | -403.82 Million | -399.4 Million |
| Effect of forex changes on cash | 32.07 Million | 94.24 Million | -40.07 Million | -44.35 Million | 9.68 Million | 6.94 Million |
| Net cash flow / Change in cash | -923.15 Million | 2.21 Billion | 468.89 Million | -1 Billion | 805.66 Million | 1.07 Billion |
| Free Cash Flow | 1.38 Billion | 2.54 Billion | 1.15 Billion | 1.18 Billion | 866.31 Million | 1.26 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 236.04 Million | 387.22 Million | 331.25 Million | 691.88 Million | 127.95 Million | 218.98 Million |
| Depreciation & Amortization | - | 194.5 Million | 194.5 Million | 825.24 Million | 215.28 Million | 215.28 Million |
| Deferred income taxes | - | - | - | -11.44 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 234.88 Million | - | -183.92 Million | 648.69 Million | -116.74 Million |
| Other non-cash items | -19.71 Million | 912.88 Million | 380.14 Million | 2.25 Billion | -717.96 Million | 217.31 Million |
| Investing Cash Flow | -748.54 Million | -420.75 Million | -185.25 Million | -1.38 Billion | -649.57 Million | -541.68 Million |
| Investments in PPE | -45.81 Million | -54.14 Million | -56.07 Million | -357.19 Million | -108.49 Million | -74.73 Million |
| Acquisitions | 13.53 Million | 384.96 Thousand | 811.98 Thousand | 10.95 Million | 9.62 Million | 503.49 Thousand |
| Investment purchases | 497 Million | -497 Million | - | 1.00 | 1.00 | -503.49 Thousand |
| Sales/Maturities of investments | 2.28 Million | - | - | 2 Million | 651.33 Thousand | 26.05 Million |
| Other Investing Activities | -702.72 Million | 130 Million | -130 Million | -1.04 Billion | -551.35 Million | -492.99 Million |
| Financing Cash Flow | -217.34 Million | -144.7 Million | -45.01 Million | -1.09 Billion | -32.56 Million | -198.23 Million |
| Debt repayment | -10 Million | - | - | -707.8 Million | -21.43 Million | -25 Million |
| Dividends payments | -134.11 Million | -134.11 Million | -31.6 Million | -134.11 Million | -134.11 Million | -192.11 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -94.86 Million | 6.33 Million | -8.91 Million | -251.47 Million | 101.54 Million | 18.88 Million |
| Accounts receivables | - | 240.24 Million | - | 485.42 Million | 485.42 Million | -8.34 Million |
| Accounts payables | - | - | - | -832.61 Million | - | - |
| Inventory | - | -5.36 Million | - | 163.26 Million | 163.26 Million | -108.39 Million |
| Other working capital | - | - | - | 2.00 | - | - |
| Cash at beginning of period | 6.17 Billion | 6.41 Billion | 5.13 Billion | 6.14 Billion | 5.62 Billion | 5.71 Billion |
| Cash at end of period | 5.42 Billion | 6.24 Billion | 5.61 Billion | 5.22 Billion | 5.22 Billion | 5.53 Billion |
| Capital Expenditure | -45.81 Million | -54.14 Million | -56.07 Million | -357.19 Million | -108.49 Million | -74.73 Million |
| Effect of forex changes on cash | 6.04 Million | 16.01 Million | 2.49 Million | 32.07 Million | 7.28 Million | 23.41 Million |
| Net cash flow / Change in cash | -750.39 Million | -173.29 Million | 483.63 Million | -923.15 Million | -398.1 Million | -181.66 Million |
| Free Cash Flow | 170.52 Million | 1.05 Billion | 655.33 Million | 1.38 Billion | 165.47 Million | 460.1 Million |
DNTUY
VYBE
IES
088260
ENGN
CTYLF